Published in Bull World Health Organ on January 01, 1974
Suppressive activity of mefloquine in sporozoite-induced human malaria. Antimicrob Agents Chemother (1976) 2.71
The treatment of malaria. Br Med J (1976) 2.42
Prophylactic activity of mefloquine hydrochloride (WR 142490) in drug-resistant malaria. Bull World Health Organ (1974) 1.45
Anti-Pneumocystis carinii activity of PS-15, a new biguanide folate antagonist. Antimicrob Agents Chemother (1993) 1.43
New tissue schizontocidal antimalarial drugs. Bull World Health Organ (1981) 1.13
Antimalarial activities and subacute toxicity of RC-12, a 4-amino-substituted pyrocatechol. Antimicrob Agents Chemother (1985) 0.77
A quinoline methanol (WR 30090) for treatment of acute malaria. Antimicrob Agents Chemother (1973) 2.85
Treatment of falciparum malaria from Vietnam with a phenanthrene methanol (WR 33063) and a quinoline methanol (WR 30090). Antimicrob Agents Chemother (1973) 2.23
Agranulocytosis due to dapsone. Ann Intern Med (1970) 2.11
A phenanthrene methanol (WR 33063) for treatment of acute malaria. Antimicrob Agents Chemother (1973) 2.05
The haemolytic effects of diaphenylsulfone (DDS) in normal subjects and in those with glucose-6-phosphate-dehydrogenase deficiency. Bull World Health Organ (1966) 1.54
Trimethoprim in therapy of acute attacks of malaria. J Clin Pharmacol J New Drugs (1968) 1.43
The effects of diaphenylsulfone (DDS) against chloroquine-resistant Plasmodium falciparum. Bull World Health Organ (1966) 1.02
Prophylaxis of malaria in man using the sulfones DFD and DDS alone and with chloroquine. Mil Med (1971) 0.99
The army malaria research program. Ann Intern Med (1969) 0.96
Malaria chemoprophylaxis with 4,4' diaminodiphenylsulfone (DDS). II. Field trial with comparison between two divisions. Mil Med (1969) 0.90
Diformyl diaminodiphenyl sufone (DFD) as an antimalarial in man. Mil Med (1970) 0.87
Prophylaxis of malaria in man using the sulfone DFD with pyrimethamine. Mil Med (1973) 0.85
Malaria chemoprophylaxis with 4,4' diaminodiphenylsulfone (DDS). I. Field trial with comparison among companies of one division. Mil Med (1969) 0.85
The chemoprophylactic use of diformyl diaminodiphenyl sulfone (DFD) in falciparum malaria. Am J Trop Med Hyg (1972) 0.85
Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother (1979) 17.49
Mefloquine (WR 142,490) in the treatment of human malaria. Science (1975) 5.20
Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg (1996) 3.36
New experimental antimalarial drugs. Adv Pharmacol Chemother (1979) 2.48
Treatment of acute falciparum malaria from Vietnam with trimethoprim and sulfalene. Am J Trop Med Hyg (1971) 2.28
Treatment of falciparum malaria from Vietnam with a phenanthrene methanol (WR 33063) and a quinoline methanol (WR 30090). Antimicrob Agents Chemother (1973) 2.23
Malaria: host-defense mechanisms and complications. Ann Intern Med (1970) 2.00
Evaluation of two phenanthrenemethanols for antimalarial activity in man: WR 122,455 and WR 171,669. Am J Trop Med Hyg (1976) 1.89
Kinetics of a new antimalarial, mefloquine. Clin Pharmacol Ther (1979) 1.66
Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group. Am J Trop Med Hyg (1999) 1.63
Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines. J Infect Dis (1999) 1.56
Antimalarial aminoalcohol alternatives to mefloquine. Acta Trop (1980) 1.54
Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg (1998) 1.48
Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum. Clin Pharmacol Ther (1997) 1.36
Malaria: treatment efficacy of halofantrine (WR 171,669) in initial field trials in Thailand. Bull World Health Organ (1988) 1.29
Phenoxypropoxybiguanides, prodrugs of DHFR-inhibiting diaminotriazine antimalarials. J Med Chem (2001) 1.29
Hyponatraemia in malaria. Ann Trop Med Parasitol (1967) 1.20
Failure of doxycycline as a causal prophylactic agent against Plasmodium falciparum malaria in healthy nonimmune volunteers. Ann Intern Med (1994) 1.16
Renal and hematologic complications of acute falciparum malaria in Vietnam. Bull N Y Acad Med (1969) 1.14
Treatment of patients with recrudescent falciparum malaria with a sequential combination of artesunate and mefloquine. Am J Trop Med Hyg (1992) 1.13
Nonpuerperal galactorrhea. N Engl J Med (1965) 1.12
Atovaquone and proguani hydrochloride compared with chloroquine or pyrimethamine/sulfodaxine for treatment of acute Plasmodium falciparum malaria in Peru. Braz J Infect Dis (2001) 1.10
Combination atovaquone and proguanil hydrochloride vs. halofantrine for treatment of acute Plasmodium falciparum malaria in children. Pediatr Infect Dis J (1999) 1.05
Population pharmacokinetics of proguanil in patients with acute P. falciparum malaria after combined therapy with atovaquone. Br J Clin Pharmacol (1996) 1.05
Structure-activity relationships of putative primaquine metabolites causing methemoglobin formation in canine hemolysates. Toxicol Appl Pharmacol (1985) 1.02
Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand. Am J Trop Med Hyg (1999) 1.01
Randomized trial of mefloquine-doxycycline, and artesunate-doxycycline for treatment of acute uncomplicated falciparum malaria. Am J Trop Med Hyg (1994) 1.01
Evaluation of the antimalarial activity of the phenanthrenemethanol halofantrine (WR 171,669). Am J Trop Med Hyg (1982) 0.95
Atovaquone and proguanil versus pyrimethamine/sulfadoxine for the treatment of acute falciparum malaria in Zambia. Clin Ther (1999) 0.95
Evaluation of the 4-pyridinemethanol WR 180,409 (enpiroline) in the treatment of induced Plasmodium falciparum infections in healthy, non-immune subjects. Am J Trop Med Hyg (1984) 0.94
Malaria prophylaxis with proguanil and sulfisoxazole in children living in a malaria endemic area. Bull World Health Organ (1989) 0.93
In vitro antimalarial activity of nucleic acid precursor analogues in the simian malaria Plasmodium knowlesi. Antimicrob Agents Chemother (1974) 0.93
Plasmodium knowlesi: in vitro evaluation of antimalarial activity of folic acid inhibitors. Exp Parasitol (1971) 0.92
Chemosuppressive field trials in Thailand. IV. The suppression of Plasmodium falciparum and Plasmodium vivax parasitemias by mefloquine (WR 142,490, A 4-quinolinemethanol). Am J Trop Med Hyg (1980) 0.91
Acute renal failure in Plasmodium falciparum malaria. Treatment of peritoneal dialysis. Arch Intern Med (1968) 0.89
Plasmodium falciparum: continuous cultivation of erythrocyte stages in plasma-free culture medium. Exp Parasitol (1984) 0.88
The absorption, distribution, and excretion in mice of the antimalarial mefloquine, erythro-2,8-bis(trifluoromethyl)-alpha-(2-piperidyl)-4-quinolinemethanol hydrochloride. Drug Metab Dispos (1979) 0.87
Plasmodium knowlesi: in vitro biosynthesis of methionine. Exp Parasitol (1976) 0.83
Comparison of beta-artemether and beta-arteether against malaria parasites in vitro and in vivo. Am J Trop Med Hyg (1993) 0.82
Trypanosoma rhodesiense: semiautomated microtesting for quantitation of antitrypanosomal activity in vitro. Exp Parasitol (1980) 0.82
Effects of nine synthetic putative metabolites of primaquine on activity of the hexose monophosphate shunt in intact human red blood cells in vitro. Biochem Pharmacol (1986) 0.81
An in vitro system for screening potential antimalarial drugs. Am J Trop Med Hyg (1970) 0.81
The absorption, distribution, and excretion in mice of a quinolinemethanol antimalarial, 2,8-bis(trifluoromethyl)-4-(1-hydroxy-3-(N-t-butylamino)propyl)quinoline phosphate (WR 184,806). Drug Metab Dispos (1976) 0.80
Plasmodium vivax from Vietnam. Response to chloroquine-primaquine. Am J Trop Med Hyg (1971) 0.80
Hazards of methoxyflurane emulsions in man. Anesth Analg (1968) 0.79
Animal toxicity of 2,2,2-trifluoroethanol. Toxicol Appl Pharmacol (1969) 0.78
Anesthesia. LXXIV. Biotransformation of fluroxene. I. Metabolism in mice and dogs in vivo. Biochem Pharmacol (1967) 0.78
American cutaneous leishmaniasis: a comparison of three sodium stibogluconate treatment schedules. Am J Trop Med Hyg (1985) 0.78
Disposition of the diastereoisomer of mefloquine in mice. Pharmacology (1982) 0.78
Erythrokinetics during treatment of acute falciparum malaria. Mil Med (1971) 0.78
Mefloquine failure in a case of falciparum malaria induced with a multidrug-resistant isolate in a non-immune subject. Am J Trop Med Hyg (1985) 0.75
Intravenous administration of a new volatile anesthetic, 2,2-dichloro-1,1-difluoroethyl methyl sulfide, in dogs and monkeys. Am J Vet Res (1968) 0.75
Chemotherapy of malaria. Annu Rev Pharmacol (1973) 0.75
The disposition of DL-3-di-n-butylamino-1-[2,6-bis(4-trifluoromethylphenyl)-4-pyridyl] propanol methanesulfonate in mice. Drug Metab Dispos (1981) 0.75
The effect of flurothyl and electroshock on pulmonary diffusion. Behav Neuropsychiatry (1970) 0.75
Methionine analogue metabolism in malaria. Trans R Soc Trop Med Hyg (1971) 0.75
Enzyme changes in Mallard ducks fed iron or lead shot. Avian Dis (1974) 0.75
The disposition of threo-alpha-(2-piperidyl)-2-trifluoromethyl-6-(4-trifluoromethylphenyl)-4-pyridinemethanol phosphate in mice. Drug Metab Dispos (1978) 0.75
Plasmodium knowlesi: in vitro biosynthesis of methionine and thymidylic acid. Exp Parasitol (1977) 0.75